Aromatase Inhibitors Reduce Contralateral Breast Cancer

Aromatase Inhibitors Reduce Contralateral Breast Cancer

When compared with women who were not treated with endocrine therapy after breast cancer, women who took tamoxifen for four years or longer had a 61 percent reduced risk of developing another cancer in the opposite breast, stated Gretchen Gierach, …

(Visited 2 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.